Searchable abstracts of presentations at key conferences in endocrinology

ea0022p77 | Bone/Calcium | ECE2010

The effect of zoledronic acid on serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone

Polyzos Stergios , Anastasilakis Athanasios , Efstathiadou Zoe , Litsas Ioannis , Kita Marina , Panagiotou Athanasios , Papatheodorou Athanasios , Arsos Georgios , Moralidis Efstratios , Barmpalios Georgios , Zafeiriadou Efthimia , Terpos Evangelos

Purpose: High serum homocysteine (HCY) and indirectly deficiency of folate and/or vitamin B12 stimulate bone resorption and adversely affect collagen cross-linking. The aim of this study was the evaluation of serum levels of HCY, folate and vitamin B12 in patients with Paget’s disease of bone (PDB) and the effect of zoledronic acid (ZOL) on their serum levels.Methods: This was a prospective open-label cohort study, with a control arm at baseline. Ni...

ea0056p632 | Clinical case reports - Thyroid/Others | ECE2018

Patient with neurofibromatosis type 1 and follicular thyroid cancer

Kanouta Fotini , Kalaitzidou Styliani , Triantafillou Eleni , Drousou Aspasia , Kyrimis Taxiarchis , Tampouratzi Dimitra , Kotis Michalis , Papadakis Georgios , Kaltzidou Victoria , Veniou Eirini , Drakopoulou Anna , Karavasili Chrysa , Mastorakos Georgios , Tertipi Athanasia

Objectives: Neurofibromatosis type 1 (NF1) is an autosomal, dominant, genetic disorder. The genetic lesion in neurofibromatosis type 1 is located at locus 17q11.2 that harbors the neurofibromin gene. Patients have 3-4 times higher possibility to develop malignancies relative to the general population. The endocrine manifestations of neurofibromatosis include precocious puberty, short stature, osteoporosis and pheochromocytoma. We present a patient with neurofibromatosis type 1...

ea0073aep570 | Reproductive and Developmental Endocrinology | ECE2021

Flow medicated dilation is associated with matrix metalloproteinase-2 in healthy postmenopausal women

Armeni Eleni , Georgiopoulos Georgios , Delialis Dimitrios , Augoulea Areti , Paschou Stavroula , Mili Nikoletta , Chondrou Asimina , Kouerinis Efthymios , Chatzivasileiou Panagiota , Kaparos Georgios , Eleftheriadis Makarios , Stamatelopoulos Kimon , Lambrinoudaki Irene

IntroductionMenopausal transition has been associated with an increase in cardiovascular risk, which is possibly linked with the hormonal imbalance following ovarian senescence. Both insulin levels and circulating androgens (FAI) have been associated with endothelial dysfunction, through studies evaluating flow mediated dilation (FMD). We aimed to investigate whether the link between these hormones and FMD might be explained by markers of oxidative stres...

ea0063p617 | Diabetes, Obesity and Metabolism 2 | ECE2019

Liraglutide restores the hyperglycemic oxidative imbalance and induces the expression of CRH, UCN1, UCN2 AND UCN3 neuropeptides in macroendothelial cells

Gougoura Sofia , Bargiota Alexandra , Koukoulis Georgos N.

Introduction: Liraglutide treatment reduces cardiovascular complications in patients with diabetes mellitus (DM), which may imply a favorable impact on the endothelial function. The aim of the present study was to investigate in vitro the effect of liraglutide on endothelial redox balance and the parallel expression of CRH, UCN1, 2 and 3 neuropeptides, under normoglycemic and hyperglycemic conditions.Methods: Macroendothelial cell line EAhy926 w...

ea0077p97 | Neuroendocrinology and Pituitary | SFEBES2021

Management of Complicated Pit-1 staining Non-functioning Pituitary macroadenoma in Pregnancy

Machenahalli Pratibha , Thandani Puja , Shad Amjad , Sherlala Khalid , Giovos Georgios , Dhingra Vandana , Randeva Harpal

Background: Incidence of non-functioning pituitary macroadenoma (NFPMA) is very rare in pregnancy. We describe a case of complicated non-functioning pituitary macroadenoma presented during pregnancy. 26 year old female at 21 weeks gestation presented to emergency services with worsening headaches, nausea and vomiting for 2-3 months. This was associated with transient double vision and confusion since 2 days. She was admitted to emergency department 3 weeks ago with vomiting an...

ea0081p537 | Adrenal and Cardiovascular Endocrinology | ECE2022

Management of persistent subclinical hypercortisolism post left adrenalectomy in a patient with primary bilateral macronodular adrenal hyperplasia with aberrant receptors

Moustaki Melpomeni , Papadimitriou Kasiani , Papanikolaou Vasiliki , Cherolidi Eleni , Rigana Maria , Kyriakopoulos Georgios , Kalogeris Nikolaos , Vryonidou Andromahi

Introduction: Endogenous subclinical hypercortisolism occurs in 5-30% of patients with adrenal incidentalomas. Adrenal adenoma is the commonest cause of autonomous cortisol secretion (ACS), while primary bilateral macronodular adrenal hyperplasia (PBMAH) is rare. In both, ACS results from activation of the cAMP/PKA pathway. This may be triggered by ligands, other than ACTH, acting upon aberrant G-protein coupled receptors (GPCRs), which may also control locally produced ACTH i...

ea0081p308 | Calcium and Bone | ECE2022

The impact of age on quality of life and frailty outcomes after parathyroidectomy in patients with primary hyperparathyroidism

Papavramidis Theodosios S. , Anagnostis Panagiotis , Pliakos Ioannis , Tzikos Georgios , Chorti Angeliki , Kotsa Kalliopi , Michalopoulos Antonios

Objective: Parathyroidectomy (PTx) improves quality of life (QoL) in patients with primary hyperparathyroidism (PHPT). Whether this effect is modified according to the patients’ age is unknown. The aim of this study was to evaluate the impact of age on the effect of PTx on QoL and frailty in patients with PHPT, six months post-PTx. Methods: This was a prospective cohort study, including patients with PHPT, admitted from January 2016 to December 2019...

ea0081p498 | Thyroid | ECE2022

Tocilizumab: an effective and low-cost treatment for recent-onset active moderate to severe graves orbitopathy. a case report

Boutzios Georgios , Chatzi Sofia , Karampela Athina , Goules Andreas , Tsourouflis Gerasimos , Tzioufas Athanasios

Introduction: Graves orbitopathy (GO) is an inflammatory condition of the orbital fat and muscles and affect 30-50% of patients with Graves’ disease. The first-line treatment of moderate to severe GO according to EUGOGO is intravenous glucocorticoids, but 20-30% of the cases appear to be corticosteroid resistant or refractory. Promising results have been described with Tocilizumab (TCZ) as a second-line moderate to severe GO treatment.Case presentat...

ea0081ep590 | Endocrine-Related Cancer | ECE2022

Pheochromocytomas and paragangliomas-real world data in a tertiary Greek center

Thanasoula Foteini , Angelousi Anna , Kyriakopoulos Georgios , Yavropoulou Maria , Kassi Evanthia , Kaltsas Gregory

Purpose: Pheochromocytomas (PCs) and paragangliomas (PGLs) are rare neuroendocrine tumors arising from chromaffin cells of the adrenal medulla and the sympathetic/parasympathetic neural ganglia, respectively. Metastatic PCs/PGLs occur in about 5-26% of cases. Their management and diagnosis still remain a challenge due to their heterogeneity, the absence of guidelines and the few prognostic tools.Aim: The aim of this study was to describe clinical and gen...

ea0081ep676 | Pituitary and Neuroendocrinology | ECE2022

Idiopathic isolated adrenocorticotropic hormone deficiency

Komzia Paraskevi , Gogakos Apostolos , Kalograni Fanny , Tsoutsas Georgios , Kita Marina , Efstathiadou Zoi

Introduction: Idiopathic Isolated Adrenocorticotropic hormone (ACTH) deficiency (IIAD) is a rare cause of secondary adrenal insufficiency. It can present with a variety of clinical symptoms, mainly chronic fatigue and euvolemic hyponatraemia, and may coexist with autoimmune disease, most commonly Hashimoto’s thyroiditis. Radiographically, an empty sella turcica image can be seen. We present 3 cases of isolated ACTH deficiency.Case 1: A 47-year-old w...